chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriosclerosis, Arteriosclerosis coronary artery, Aspartate aminotransferase increased, Asthenia, Atrial fibrillation
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Basophil percentage decreased, Blood albumin decreased, Blood alkaline phosphatase normal, Blood bicarbonate normal, Blood bilirubin normal
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood calcium decreased, Blood chloride decreased, Blood creatinine increased, Blood glucose normal, Blood potassium decreased
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, Blood urea increased, C-reactive protein, C-reactive protein increased, COVID-19
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cardiomegaly, Cataract operation, Chest X-ray abnormal, Chronic kidney disease
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Creatinine renal clearance, Decreased appetite, Dyspnoea exertional
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram QRS complex, Electrocardiogram QT interval, Electrocardiogram T wave abnormal, Electrocardiogram abnormal, Eosinophil percentage decreased
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Full blood count, Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Immature granulocyte count, International normalised ratio increased, Lung opacity, Lymphocyte percentage decreased, Malaise
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased, Mean cell volume normal, Mean platelet volume normal, Metabolic function test
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test abnormal, Monocyte percentage increased, Neutrophil percentage increased, Platelet count normal, Prone position
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Protein total normal, Prothrombin time prolonged, QRS axis, Red blood cell count decreased, Red blood cell nucleated morphology
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Red cell distribution width normal, SARS-CoV-2 test positive, Wheezing, White blood cell count normal
Clinical narrative: Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Dizziness, Electrocardiogram
Clinical narrative: Client c/o feeling dizzy, no loss of consciousness, no other complaint was made.  Client was examined by medic on site.  Upon assessment client transferred to Hospital via ambulance due to elevated BP 190/100 for further evaluation.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Acute left ventricular failure, Asthenia, Atrial fibrillation, COVID-19, Chest X-ray normal
Clinical narrative: Patient discharged from (8) day inpatient admission and returned to ED same day for generalized weakness and inability to cae for herself. Requesting home care.  The patient is a 76 y.o. female with a history of chronic diastolic CHF, a.fib on eliquis, HTN, HLD, and GERD admitted on 11/26/2021 with progressive SOB and edema secondary to acute on chronic diastolic heart failure in the setting of diuretic non adnerence. Pt reported dark stool prior to admission as well. +COVID test on admission.  A fib with RVR present at time of admission.    Pt initiated on supplemental O2 and IV diuresis.  Significant COVID pneumonia not suspected given CXR findings, respiratory failure felt to be secondary to CHF instead. Decadron was started, remdesivir held as no significant pneumonia on x-ray and transaminitis. RUQ U/S showed mild increased liver echogenicity, suggesting underlying hepatocellular disease. LFTs down-trended. Recent echo 8/2021 with EF 61%, mild pulmonary HTN. She diuresed well and was weaned to room air. Transitioned back to oral torsemide.   She reported melena on admission so home eliquis held initally. Hemoglobin remained stable without signs of bleeding and eliquis was resumed without evidence of bleeding. PT/OT evaluated and recommended discharge home with assist and HHC.    Patient had stopped taking torsemide at home and she felt it was causing her to feel "unwell". Discharge plans coordinated with cardiology, advised discharge on lasix 40 mg daily with KCl 20meq. She was advised to monitor her weights closely and have follow up labs checked within 5-7 days. Cardiology arranged virtual appointment on 12/6. She was felt stable for discharge on 12/2. She will complete remaining 3 days of torsemide for 10 day course. She was discharged home in stable condition with family.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic left ventricular failure, Condition aggravated, Dyspnoea, Echocardiogram normal, Ejection fraction normal
Clinical narrative: Patient discharged from (8) day inpatient admission and returned to ED same day for generalized weakness and inability to cae for herself. Requesting home care.  The patient is a 76 y.o. female with a history of chronic diastolic CHF, a.fib on eliquis, HTN, HLD, and GERD admitted on 11/26/2021 with progressive SOB and edema secondary to acute on chronic diastolic heart failure in the setting of diuretic non adnerence. Pt reported dark stool prior to admission as well. +COVID test on admission.  A fib with RVR present at time of admission.    Pt initiated on supplemental O2 and IV diuresis.  Significant COVID pneumonia not suspected given CXR findings, respiratory failure felt to be secondary to CHF instead. Decadron was started, remdesivir held as no significant pneumonia on x-ray and transaminitis. RUQ U/S showed mild increased liver echogenicity, suggesting underlying hepatocellular disease. LFTs down-trended. Recent echo 8/2021 with EF 61%, mild pulmonary HTN. She diuresed well and was weaned to room air. Transitioned back to oral torsemide.   She reported melena on admission so home eliquis held initally. Hemoglobin remained stable without signs of bleeding and eliquis was resumed without evidence of bleeding. PT/OT evaluated and recommended discharge home with assist and HHC.    Patient had stopped taking torsemide at home and she felt it was causing her to feel "unwell". Discharge plans coordinated with cardiology, advised discharge on lasix 40 mg daily with KCl 20meq. She was advised to monitor her weights closely and have follow up labs checked within 5-7 days. Cardiology arranged virtual appointment on 12/6. She was felt stable for discharge on 12/2. She will complete remaining 3 days of torsemide for 10 day course. She was discharged home in stable condition with family.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Faeces discoloured, Haemoglobin normal, Hepatocellular injury, Impaired self-care, Liver function test decreased
Clinical narrative: Patient discharged from (8) day inpatient admission and returned to ED same day for generalized weakness and inability to cae for herself. Requesting home care.  The patient is a 76 y.o. female with a history of chronic diastolic CHF, a.fib on eliquis, HTN, HLD, and GERD admitted on 11/26/2021 with progressive SOB and edema secondary to acute on chronic diastolic heart failure in the setting of diuretic non adnerence. Pt reported dark stool prior to admission as well. +COVID test on admission.  A fib with RVR present at time of admission.    Pt initiated on supplemental O2 and IV diuresis.  Significant COVID pneumonia not suspected given CXR findings, respiratory failure felt to be secondary to CHF instead. Decadron was started, remdesivir held as no significant pneumonia on x-ray and transaminitis. RUQ U/S showed mild increased liver echogenicity, suggesting underlying hepatocellular disease. LFTs down-trended. Recent echo 8/2021 with EF 61%, mild pulmonary HTN. She diuresed well and was weaned to room air. Transitioned back to oral torsemide.   She reported melena on admission so home eliquis held initally. Hemoglobin remained stable without signs of bleeding and eliquis was resumed without evidence of bleeding. PT/OT evaluated and recommended discharge home with assist and HHC.    Patient had stopped taking torsemide at home and she felt it was causing her to feel "unwell". Discharge plans coordinated with cardiology, advised discharge on lasix 40 mg daily with KCl 20meq. She was advised to monitor her weights closely and have follow up labs checked within 5-7 days. Cardiology arranged virtual appointment on 12/6. She was felt stable for discharge on 12/2. She will complete remaining 3 days of torsemide for 10 day course. She was discharged home in stable condition with family.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Melaena, Oedema, Pulmonary hypertension, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient discharged from (8) day inpatient admission and returned to ED same day for generalized weakness and inability to cae for herself. Requesting home care.  The patient is a 76 y.o. female with a history of chronic diastolic CHF, a.fib on eliquis, HTN, HLD, and GERD admitted on 11/26/2021 with progressive SOB and edema secondary to acute on chronic diastolic heart failure in the setting of diuretic non adnerence. Pt reported dark stool prior to admission as well. +COVID test on admission.  A fib with RVR present at time of admission.    Pt initiated on supplemental O2 and IV diuresis.  Significant COVID pneumonia not suspected given CXR findings, respiratory failure felt to be secondary to CHF instead. Decadron was started, remdesivir held as no significant pneumonia on x-ray and transaminitis. RUQ U/S showed mild increased liver echogenicity, suggesting underlying hepatocellular disease. LFTs down-trended. Recent echo 8/2021 with EF 61%, mild pulmonary HTN. She diuresed well and was weaned to room air. Transitioned back to oral torsemide.   She reported melena on admission so home eliquis held initally. Hemoglobin remained stable without signs of bleeding and eliquis was resumed without evidence of bleeding. PT/OT evaluated and recommended discharge home with assist and HHC.    Patient had stopped taking torsemide at home and she felt it was causing her to feel "unwell". Discharge plans coordinated with cardiology, advised discharge on lasix 40 mg daily with KCl 20meq. She was advised to monitor her weights closely and have follow up labs checked within 5-7 days. Cardiology arranged virtual appointment on 12/6. She was felt stable for discharge on 12/2. She will complete remaining 3 days of torsemide for 10 day course. She was discharged home in stable condition with family.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Transaminases increased, Ultrasound abdomen abnormal
Clinical narrative: Patient discharged from (8) day inpatient admission and returned to ED same day for generalized weakness and inability to cae for herself. Requesting home care.  The patient is a 76 y.o. female with a history of chronic diastolic CHF, a.fib on eliquis, HTN, HLD, and GERD admitted on 11/26/2021 with progressive SOB and edema secondary to acute on chronic diastolic heart failure in the setting of diuretic non adnerence. Pt reported dark stool prior to admission as well. +COVID test on admission.  A fib with RVR present at time of admission.    Pt initiated on supplemental O2 and IV diuresis.  Significant COVID pneumonia not suspected given CXR findings, respiratory failure felt to be secondary to CHF instead. Decadron was started, remdesivir held as no significant pneumonia on x-ray and transaminitis. RUQ U/S showed mild increased liver echogenicity, suggesting underlying hepatocellular disease. LFTs down-trended. Recent echo 8/2021 with EF 61%, mild pulmonary HTN. She diuresed well and was weaned to room air. Transitioned back to oral torsemide.   She reported melena on admission so home eliquis held initally. Hemoglobin remained stable without signs of bleeding and eliquis was resumed without evidence of bleeding. PT/OT evaluated and recommended discharge home with assist and HHC.    Patient had stopped taking torsemide at home and she felt it was causing her to feel "unwell". Discharge plans coordinated with cardiology, advised discharge on lasix 40 mg daily with KCl 20meq. She was advised to monitor her weights closely and have follow up labs checked within 5-7 days. Cardiology arranged virtual appointment on 12/6. She was felt stable for discharge on 12/2. She will complete remaining 3 days of torsemide for 10 day course. She was discharged home in stable condition with family.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Death
Clinical narrative: PATIENT SUFFERED A STROKE SOMETIME THE NIGHT OF 11/28/21 OR THE MORNING OF 11/29/21 RESULTING IN HOSPITALIZATION AND DEATH. MAY NOT HAVE BEEN RELATED TO VACCINE, BUT HAPPENED VERY CLOSE TO VACCINATION.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Error: Improper Storage (temperature)-
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Tinnitus-Medium, Systemic: Visual Changes/Disturbances-Medium, Systemic: Weakness-Medium
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Syncope, Tinnitus, Unresponsive to stimuli, Visual impairment
Clinical narrative: Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Tinnitus-Medium, Systemic: Visual Changes/Disturbances-Medium, Systemic: Weakness-Medium
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Error: Patient Too Young for Vaccine Administered-
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dyspnoea, Fatigue, Headache
Clinical narrative: Immediately after injection shortness of breath set-in.  About 3 hours after injection chills and body aches set in. About 5 hours after injection fatigue, nausea and headache set in. At 10 hours vomiting started. At 24 hours diarrhea started and congestion.  Symptoms lasted 5 days.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Respiratory tract congestion, Vomiting
Clinical narrative: Immediately after injection shortness of breath set-in.  About 3 hours after injection chills and body aches set in. About 5 hours after injection fatigue, nausea and headache set in. At 10 hours vomiting started. At 24 hours diarrhea started and congestion.  Symptoms lasted 5 days.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Dyspnoea, Flushing, Hyperhidrosis, Hypertension
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypertension-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus, Throat tightness
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypertension-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: Error: Wrong Route (SC, IM, etc.)-
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Systemic: bumps all over body-Medium, Additional Details: patient says he got bumps all over body, slight itch